| Literature DB >> 34822237 |
Mariano Martínez Espinosa1, Vitesinha Rosa Dos Santos Almeida2, Vagner Ferreira do Nascimento3.
Abstract
OBJECTIVES: To identify the proportion of poor of glycemic control and associated factors among people with type 2 diabetes attending a regional reference outpatient clinic in Mato Grosso (Brazil).Entities:
Keywords: control; glycated hemoglobin A; risk factors; type 2 diabetes mellitus
Mesh:
Substances:
Year: 2021 PMID: 34822237 PMCID: PMC8912167 DOI: 10.17533/udea.iee.v39n3e10
Source DB: PubMed Journal: Invest Educ Enferm ISSN: 0120-5307
Crude prevalence ratios of sociodemographic factors associated with elevated glycated hemoglobin test. Cuiabá, Mato Grosso, Brazil, 2020
| Factors | Category | Glycated hemoglobin | Glycated hemoglobin | Glycated hemoglobin | Glycated hemoglobin | PRc | 95% CI | |
|---|---|---|---|---|---|---|---|---|
| Factors | Category | Elevated | Elevated | Normal | Normal | PRc | 95% CI | |
| Factors | Category | % | % | PRc | 95% CI | |||
| Sex( | Male | 41 | 45.05 | 50 | 54.95 | 0.94 | 0.72 ; 1.21 | 0.610 |
| Female | 119 | 48.18 | 128 | 51.82 | 1.00 | - | - | |
| ≤59 years | 97 | 62.18 | 59 | 37.82 | 1.80 | 1.42; 2.27 | <0.001 | |
| 60 years or over | 63 | 34.62 | 119 | 65.38 | 1.00 | - | - | |
| Skin color (N=332) | Non-white | 150 | 47.62 | 165 | 52.38 | 1.16 | 0.65; 2.07 | 0.604 |
| White | 7 | 41.18 | 10 | 58.82 | 1.00 | - | - | |
| No partner | 45 | 45.92 | 53 | 54.08 | 0.97 | 0.75; 1.25 | 0.813 | |
| With partner | 107 | 47.35 | 119 | 52.65 | 1.00 | - | - | |
| No information | 24 | 58.54 | 17 | 41.46 | 1.11 | 0.79; 1.56 | 0.554 | |
| ≤8 years | 93 | 43.46 | 121 | 56.54 | 0.82 | 0.63; 1.08 | 0.170 | |
| >8 years | 38 | 52.78 | 34 | 47.22 | 1.00 | - | - | |
| Other municipalities | 46 | 56.79 | 35 | 43.21 | 1.28 | 1.01; 1.62 | 0.051 | |
| Cuiabá | 114 | 44.36 | 143 | 55.64 | 1.00 | - | - |
PRc: crude prevalence ratio. 95% CI: 95% confidence interval. p: Significance level considering the chi-square distribution.
Crude prevalence ratios of lifestyle factors and clinical conditions associated with elevated glycated hemoglobin test. Cuiabá, Mato Grosso, Brazil, 2020
| Category | Glycated hemoglobin | Glycated hemoglobin | Glycated hemoglobin | Glycated hemoglobin | PRc | 95% IC | |
|---|---|---|---|---|---|---|---|
| Category | Elevated | Elevated | Normal | Normal | PRc | 95% IC | |
| Category | % | % | PRc | 95% IC | |||
| Physical activity ( | |||||||
| No | 118 | 56.46 | 91 | 43.5 | 1.87 | <0.001 | |
| No information | 10 | 43.48 | 13 | 56.5 | 1.44 | 0.218 | |
| Yes | 32 | 30.19 | 74 | 69.8 | 1.00 | - | - |
| Postprandial glucose ( | |||||||
| ≥180 (mg/dL) | 105 | 63.25 | 61 | 36.75 | 2.30 | <0.001 | |
| <180 (mg/dL) | 36 | 27.48 | 95 | 72.52 | 1.00 | - | - |
| Fasting glucose ( | |||||||
| ≤70 and ≥100 (mg/dL) | 147 | 51.40 | 139 | 48.60 | 2.24 | <0.001 | |
| 70-100 (mg/dL) | 11 | 22.92 | 37 | 77.08 | 1.00 | - | - |
| Use of insulin ( | 116 | 62.70 | 69 | 37.3 | 2.18 | <0.001 | |
| Diagnosis time ( | |||||||
| >10 years | 72 | 55.38 | 58 | 44.6 | 1.29 | 0.026 | |
| ≤10 years | 88 | 42.93 | 117 | 57.1 | 1.00 | - | - |
| Cardiovascular diseases ( | |||||||
| High risk | 79 | 55.63 | 63 | 44.37 | 1.42 | 0.004 | |
| Diseases | 11 | 61.11 | 7 | 38.89 | 1.55 | 0.074 | |
| No | 70 | 39.33 | 108 | 60.67 | 1.00 | - | - |
| Systemic arterial hypertension ( | 114 | 44.53 | 142 | 55.5 | 0.79 | 0.068 | |
| Amputation ( | 2 | 22.22 | 7 | 77.8 | 0.46 | 0.126* | |
| Obesity ( | 72 | 52.17 | 66 | 47.8 | 1.19 | 0.139 | |
| Hospitalization ( | 6 | 75.00 | 2 | 25.00 | 1.61 | 0.156* | |
| Retinopathy ( | 23 | 54.76 | 19 | 45.2 | 1.18 | 0.303 | |
| Neuropathy ( | 9 | 56.25 | 7 | 43.75 | 1.20 | 0.464 | |
| Nephropathy ( | 15 | 41.67 | 21 | 58.3 | 0.87 | 0.471 | |
| Ulcers ( | 13 | 54.17 | 11 | 45.8 | 1.16 | 0.487 | |
| Dyslipidemia ( | 81 | 48.21 | 87 | 51.8 | 1.04 | 0.748 | |
| Psychological anxiety and depression ( | 36 | 47.37 | 40 | 52.63 | 1.00 | 0.995 |
PRc: crude prevalence ratio. 95% CI: 95% confidence interval. p: significance level considering the chi-square distribution. *: Fisher’s exact test.
Adjusted prevalence ratios for factors associated with elevated glycated hemoglobin test. Cuiabá, Mato Grosso, Brazil, 2020
| Category | PRa | 95% IC | |
|---|---|---|---|
| Insulin use | |||
| Yes | 2.03 | (1.54; 2.69) | <0.001 |
| No | 1.00 | - | - |
| Fasting glucose | |||
| ≤70 and ≥100 (mg/dL) | 2.00 | (1.23; 3.27) | 0.006 |
| De 70-100 (mg/dL) | 1.00 | - | - |
| Postprandial glucose | |||
| ≥180 (mg/dL) | 1.76 | (1.35; 2.29) | <0.001 |
| <180 (mg/dL) | 1.00 | - | - |
| Physical activity | |||
| No | 1.62 | (1.21; 2.16) | 0.001 |
| No information | 1.06 | (0.63; 1.79) | 0.825 |
| Yes | 1.00 | - | - |
| Interaction between age group and disease diagnosis time | |||
| ≤59 years and >10 years | 1.58 | (1.01; 2.46) | 0.046 |
| 60 years or over and ≤10 years | 1.00 | - | - |
| Origin | |||
| Other municipalities | 1.41 | (1.13; 1.76) | 0.003 |
| Cuiabá | 1.00 | - | - |
| Age group | |||
| ≤59 years | 1.39 | (1.05; 1.83) | 0.021 |
| 60 years or over | 1.00 | - | - |
| Diagnosis time | |||
| >10 years | 0.76 | (0.52; 1.11) | 0.163 |
| ≤10 years | 1.00 | - | - |
| Systemic arterial hypertension | |||
| Yes | 0.79 | (0.64; 0.98) | 0.033 |
| No | 1.00 | - | - |
PRa: prevalence ratio adjusted by Poisson’s multiple regression model with robust variance. CI: confidence interval.